Current Ratio in % of Gain Therapeutics, Inc. from Q3 2021 to Q3 2025

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Gain Therapeutics, Inc. quarterly Current Ratio history and change rate from Q3 2021 to Q3 2025.
Gain Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 2 %, a 23.3% decline year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Change (%)

Gain Therapeutics, Inc. Quarterly Current Ratio (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	2	-1	-23.3%	30 Sep 2025
Q2 2025	2	-0	-14.3%	30 Jun 2025
Q1 2025	2	-0	-6%	31 Mar 2025
Q4 2024	2	-0	-8.6%	31 Dec 2024
Q3 2024	3	-0	-11.8%	30 Sep 2024
Q2 2024	2	-1	-33.3%	30 Jun 2024
Q1 2024	2	-2	-45.2%	31 Mar 2024
Q4 2023	3	-4	-52.9%	31 Dec 2023
Q3 2023	3	-5	-59.8%	30 Sep 2023
Q2 2023	4	-6	-58.4%	30 Jun 2023
Q1 2023	5	-7	-57.4%	31 Mar 2023
Q4 2022	6	-9	-57.3%	31 Dec 2022
Q3 2022	8	-5	-37%	30 Sep 2022
Q2 2022	10			30 Jun 2022
Q1 2022	12			31 Mar 2022
Q4 2021	15			31 Dec 2021
Q3 2021	13			30 Sep 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.